PCC Rokit (PCR) Q4 2025 earnings summary

Executive summary

• Consolidated revenue for 2025 was 1,801 million PLN, down 7.5% year-over-year, but sales volume increased due to product and customer diversification.

• EBITDA for 2025 was 281 million PLN, a 25% decrease from 2024; net profit dropped 57% to 61.5 million PLN.

• Despite challenging market conditions, investment projects continued, and the group maintained a strong presence in key industrial sectors.

Financial highlights

• Revenue: 1,801 million PLN in 2025, down from 1,947 million PLN in 2024.

• EBITDA: 281 million PLN in 2025, down 25% from 374 million PLN in 2024.

• Net profit: 61.5 million PLN in 2025, down 57% from 143 million PLN in 2024.

• Net cash flow: -127.7 million PLN in 2025, further negative after -40.5 million PLN in 2024.

• Investments (CAPEX): 171 million PLN in 2025.

Outlook and guidance

• Ongoing investment in production capacity, including expansion of electrolysis and alkoxylation projects, with completion targets in 2026 and 2028.

• Focus on cost reduction and flexibility to adapt to market volatility.